SCI Foundation is now Unlimit Health. Learn more about what the change means for our ongoing efforts to eliminate neglected tropical diseases

Key facts

  • Population: 99.3 million
  • Percentage living in poverty: 23.5%
  • Number requiring treatment for intestinal worm infections: 19.4 million*
  • Number requiring treatment for schistosomiasis: 15.9 million*

Programme information

  • Programme start date: 2013
  • Treatments delivered in FY 2019-20: 25,051,529^
  • Numbers treated to date: 35,098,201^
  • Programme coverage status: Scaling up to reach all at-risk SAC^^

Stories

People are exposed to neglected tropical diseases (NTDs) due to their daily household needs and livelihood activities, as shown in this story from Ethiopia.

Meet Kibet (below), a primary school student in Ethiopia. Learn more about how the programmes we support have helped him.

Read about his story

Kibet, a primary school student in Ethiopia

Footnotes:

* Data from WHO schistosomiasis and soil-transmitted helminth database.

^ For every treatment provided against schistosomiasis, treatments are also offered against intestinal worm infections where both diseases are present. Treatment numbers are for schistosomiasis only and dating from 2010 when the current reporting system was established. Numbers from January 2020.

^^ We support the programme in-line with the country’s strategic plan. As such, individuals other than school-age children may be treated.

Where We Work

As a top rated international development nonprofit, we support deworming programmes across sub-Saharan Africa in the following countries:

Burundi

Burundi is one of the smallest countries in Africa, and its more than 11 million inhabitants make it one of the most population dense countries on the continent. The country is endemic for parasitic worm infections including schistosomiasis, and following several years of treatment, we’re supporting the local government to eliminate these diseases for good.

View our work in Burundi

Côte d’Ivoire

Parasitic worm infections are debilitating and disproportionately affect the poor and vulnerable, particularly children. While lack of awareness and limited access to clean water and sanitation continue to present challenges, Côte d’Ivoire’s national programme is committed to achieving the elimination of schistosomiasis. By supporting the Ministry of Health, we’re continuing to fight these diseases using sustainable interventions.

View our work in Côte d’Ivoire

Uganda

Parasitic worm infections are debilitating and disproportionately affect the poor and vulnerable, particularly children. While lack of awareness and limited access to clean water and sanitation continue to present challenges, Uganda’s national programme is committed to achieving the elimination of schistosomiasis. By supporting the Ministry of Health, we’re continuing to fight these diseases using sustainable interventions.

View our work in Uganda

Ethiopia

Ethiopia, in the horn of Africa, is the most populous land-locked country in the world. It bears a significant burden of parasitic worm infections, including schistosomiasis, but we’re supporting the Ministry of Health to implement a multi-year national programme for the control and elimination of these diseases.

View our work in Ethiopia

DRC

Parasitic worm infections (such as schistosomiasis) often trap people in a cycle of poverty, and almost half of the population of the Democratic Republic of the Congo (DRC) is living below the national poverty line. We’re supporting the local government to eliminate these infections.

View our work in DRC

Liberia

Around 40% of Liberia’s population is affected by parasitic worm infections (such as schistosomiasis), but we’ve successfully worked with its government to reach all at-risk school age children with treatment.

View our work in Liberia

Madagascar

Madagascar, one of the largest islands in the world, is a low-income country that has suffered from several years of reduced international aid. In most endemic areas in the country, people have gone untreated for many years. We’re supporting the Ministry of Public Health and Education to reach the largest possible number of people affected by schistosomiasis.

View our work in Madagascar

Niger

A majority of Niger’s population lives in rural areas and almost half of Nigerians live below the poverty line. Access to clean water and sanitation is a daily challenge, but by supporting the Ministry of Health we’ve helped to deliver over 10 million treatments for schistosomiasis and soil-transmitted helminths, and have reached all at-risk school-age children.

View our work in Niger

Sudan

With over half of Sudan’s population unable to use improved water and sanitation, over 20 million people need treatment for parasitic worm infections and schistosomiasis. We’re supporting the country’s government to help maintain an elimination programme with national reach.

View our work in Sudan

Tanzania

Despite the country’s control programme reaching national coverage, the size of population at risk is still significant. We support the Ministry of Health and Pemba’s Public Health Laboratory-Ivo de Carneri to deliver treatments against parasitic worm infections, including schistosomiasis.

View our work in Tanzania

Zanzibar

All 11 districts across both islands in Zanzibar are endemic for soil-transmitted helminthiasis (STH) and all but one on Unguja are endemic for urogenital schistosomiasis (SCH) with prevalence ranging from 0.4 – 4.8%.

View our work in Zanzibar

Malawi

All 29 of Malawi’s health districts are endemic for schistosomiasis, with both urogenital and intestinal schistosomiasis present within the country. Disease levels in Malawi range from 1.3% to 25.4%, which are classified as low to moderate prevalence, according to the World Health Organization’s (WHO) endemicity categories.

View our work in Malawi

Unlimit Health logo

Please help end parasitic disease

Sign up for our mailing list to stay updated with important news, inspiring stories, the latest research, and opportunities to support our vital work.

Name
This field is for validation purposes and should be left unchanged.

We’ll never distribute your email address to any third party. You may opt out at any time. View our privacy policy.